Inogen, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Loss per Share (Tables)

Loss per Share (Tables)

9 Months Ended

Sep. 30, 2024

The computation of EPS is as follows:


	Three months ended September 30,						Nine months ended September 30,
	2024			2023			2024			2023
Numerator—basic and diluted:
Net loss	$	(5,963	)	$	(45,719	)	$	(26,131	)	$	(75,894	)

Denominator:
Weighted average common shares - basic common stock (1)		23,751,168			23,231,217			23,589,836			23,129,795
Weighted average common shares - diluted common stock		23,751,168			23,231,217			23,589,836			23,129,795

Net loss per share - basic common stock	$	(0.25	)	$	(1.97	)	$	(1.11	)	$	(3.28	)
Net loss per share - diluted common stock (2)	$	(0.25	)	$	(1.97	)	$	(1.11	)	$	(3.28	)

Denominator calculation from basic to diluted:
Weighted average common shares - basic common stock (1)		23,751,168			23,231,217			23,589,836			23,129,795
Stock options and other dilutive awards		764,761			149,236			620,943			301,309
Weighted average common shares - diluted common stock		24,515,929			23,380,453			24,210,779			23,431,104

Shares excluded from diluted weighted average shares:
Stock options		—			57,364			—			54,498
Restricted stock units and restricted stock awards		252,576			1,186,231			337,866			849,398
Shares excluded from diluted weighted average shares		252,576			1,243,595			337,866			903,896

(1)

Unvested restricted stock units and restricted stock awards are not included as shares outstanding in the calculation of basic earnings per share. Vested restricted stock units and restricted stock awards are included in basic earnings per share if all vesting and performance criteria have been met. Performance-based restricted stock units and restricted stock awards are included in the number of shares used to calculate diluted earnings per share as long as all applicable performance criteria are met, and their effect is dilutive. Restricted stock awards are eligible to receive all dividends declared on the Company’s common shares during the vesting period; however, such dividends are not paid until the restrictions lapse.

(2)

Due to net losses for the three and nine months ended September 30, 2024 and September 30, 2023, diluted loss per share is the same as basic.